South Africa: Swiss pharmaceutical challenges India's Patent Act

Swiss pharmaceutical company Novartis has given South Africa the assurance that its court challenge of India's Patent Act will not affect access to cheaper generic drugs. However, South African Aids and health care activists believe a successful challenge will limit competition and increase prices.